"Each decade earlier that LDL lowering is started appears to result in a progressively greater proportional reduction in the risk of major cardiovascular events for the same reduction in LDL" Prof Kausik Ray FMedSci nature.com/articles/s4156…

Check out our journal club with OPCI on ORBITA-STAR and the symptom stratified analysis of ORBITA-2 Rasha Al-Lamee Florentina Simader NHLI

"Intracoronary imaging guidance by IVUS or OCT is recommended for performing PCI on anatomically complex lesions, in particular left main stem, true bifurcations and long lesions. " EHJ2024 OCTOBER Trial Evald Høj Christiansen Gregg W. Stone MD Lene Nyhus Andreasen Ziad Ali Dr Peter O'Kane Omeed Neghabat

#ESCCongress ➡️what’s new with #BP guidelines?? #MedTwitter #CardioTwitter #CardioX ❤️ new category of 'Elevated BP' with BP 120-139/70-89 mmHg. ❤️ new systolic BP treatment target range of 120-129 mmHg for most patients receiving BP-lowering meds ❤️ pragmatic

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

ABYSS trial showed interrupting B-blocker in MI with preserved LVEF > 40% is not different from continuing B-blockers with regards to composite of death, MI, stroke, or CV hospitalization. Interrupting B-blockers resulted in higher hospitalization rate #ESCCongress #cardiology

#FullPhysiology class I B. No more excuses!💪

Bye bye CHA2DS2-VASc score, hello CHA2DS2-VA score 🫀 (Problem is, they both sound identical when you pronounce them!) #ESCCongress

Cat…. Pigeon?

Interventional cardiologists going to outpatient clinic

🌍 Geographical #Inequality in Access to Aortic Valve Intervention in England. A report from the UK #TAVI Registry & National Adult Cardiac Surgery Audit 🇬🇧 #TAVR #SAVR #CardioTwitter #Cardiology Radcliffe Cardiology #ICR³ David Hildick-Smith 📚 icrjournal.com/articles/geogr…..

Beautiful

🚨Morning #ESCCongress2024. PCI complications can happen any time- even on a Sunday! Join Angela McInerney Davide Cao thomas modine Nick Curzen & I to discuss dissection, no-reflow, lost kit & more in this session led by Dr Shrilla Banerjee MD FRCP 💙 George Dangas, MD, MACC, MSCAI 📍Rm Prague ⏱️Sun 1 Sep 8:15 am

Davide Cao Sinjini Biswas An Excellent intervention session at the #ESCCongress expertly chaired and well-discussed by Dr Shrilla Banerjee MD FRCP 💙 George Dangas, MD, MACC, MSCAI curzen

According to the results of the TIGHT K randomized trial, the widespread practice of seeking to maintain high-normal serum potassium concentration after CABG surgery can be abandoned. This will reduce health care costs and decrease patient risk from an unnecessary intervention

SCOFF : 🇦🇺RCT presented by David Ferreira -No increase in complications if patients ate normally vs fasting before minimally invasive 🫀 procedures under sedation. -Higher Patient satisfaction without fasting #ESCCongress European Society of Cardiology Salvatore Brugaletta Nicola Ryan Erik Rafflenbeul

In patients with AMI and cardiogenic shock with planned revascularization, routine early MCS does not reduce 6-month all-cause mortality irrespective of device type. Higher rate of bleeding and peripheral complications with MCS #ESCCongress

In patients with de novo, non-complex coronary artery disease, irrespective of vessel diameter, a strategy of DCB angioplasty with rescue stenting did not achieve non-inferiority compared with the intended DES implantation in terms of the DoCE at 2 years. This is the first of a

Our publ in Lancet: IPD pooled analysis of all 6 RCTs in which 23,256 pts were treated with 1-yr DAPT vs. 2wks-3mos DAPT (median 78d) followed by ticagrelor monoRx. MACE favored short DAPT, and major bleeding and mortality were reduced. Similar results in CCS & ACS, even post-MI.

ANNOUNCEMENT. BRITISH - an rct of 1252 PTS with NICM and scar by CMR, funded British Heart Foundation has been given greenlight post vanguard! So the trial WILL finish. With thanks to all the sites involved. We have 236 patients randomised already at 40 UK sites. Southampton CTU curzen